Clare Market Investments’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $228K | Sell |
1,801
-270
| -13% | -$34.2K | 0.05% | 131 |
|
|
2025
Q1 | $265K | Sell |
2,071
-524
| -20% | -$67K | 0.07% | 110 |
|
|
2024
Q4 | $343K | Sell |
2,595
-1,105
| -30% | -$146K | 0.08% | 111 |
|
|
2024
Q3 | $539K | Buy |
3,700
+747
| +25% | +$109K | 0.14% | 84 |
|
|
2024
Q2 | $405K | Sell |
2,953
-505
| -15% | -$69.3K | 0.11% | 93 |
|
|
2024
Q1 | $474K | Sell |
3,458
-113
| -3% | -$15.5K | 0.15% | 95 |
|
|
2023
Q4 | $485K | Buy |
3,571
+4
| +0.1% | +$543 | 0.17% | 82 |
|
|
2023
Q3 | $436K | Sell |
3,567
-1
| -0% | -$122 | 0.17% | 77 |
|
|
2023
Q2 | $453K | Sell |
3,568
-149
| -4% | -$18.9K | 0.17% | 76 |
|
|
2023
Q1 | $480K | Sell |
3,717
-200
| -5% | -$25.8K | 0.2% | 62 |
|
|
2022
Q4 | $514K | Buy |
3,917
+2
| +0.1% | +$263 | 0.24% | 59 |
|
|
2022
Q3 | $458K | Buy |
3,915
+902
| +30% | +$106K | 0.2% | 70 |
|
|
2022
Q2 | $354K | Buy |
3,013
+301
| +11% | +$35.4K | 0.15% | 88 |
|
|
2022
Q1 | $353K | Sell |
2,712
-69
| -2% | -$8.99K | 0.11% | 113 |
|
|
2021
Q4 | $424K | Buy |
2,781
+81
| +3% | +$12.4K | 0.12% | 88 |
|
|
2021
Q3 | $437K | Sell |
2,700
-298
| -10% | -$48.2K | 0.13% | 86 |
|
|
2021
Q2 | $491K | Buy |
2,998
+200
| +7% | +$32.7K | 0.16% | 72 |
|
|
2021
Q1 | $421K | Sell |
2,798
-349
| -11% | -$52.6K | 0.16% | 73 |
|
|
2020
Q4 | $477K | Buy |
3,147
+1,251
| +66% | +$190K | 0.2% | 59 |
|
|
2020
Q3 | $257K | Buy |
1,896
+150
| +9% | +$20.3K | 0.13% | 88 |
|
|
2020
Q2 | $239K | Sell |
1,746
-298
| -15% | -$40.7K | 0.14% | 71 |
|
|
2020
Q1 | $220K | Sell |
2,044
-534
| -21% | -$57.5K | 0.19% | 68 |
|
|
2019
Q4 | $311K | Buy |
+2,578
| New | +$311K | 0.22% | 67 |
|